About the Study

We’re inviting people living with GVHD to join a clinical research study to help improve care and support. The study is testing a virtual workshop called Horizons, designed to build resilience and foster connection among people with GVHD. This research is a collaborative effort between Massachusetts General Hospital, Harvard Medical School, and the University of Miami/Sylvester Comprehensive Cancer Center.

Participants will be randomly assigned to one of two groups:

Horizons Group: You’ll take part in Horizons, an  8-week online workshop with 6-8 other participants. Sessions will be led by two clinicians with expertise in transplant care and behavioral health. Each session will focus on fostering connections and practicing skills for managing GVHD.

Educational Group: You’ll receive a GVHD booklet that includes evidence-based tips and information on managing GVHD.

All participants will be asked to complete 3 brief surveys over the course of the study. Your input will help us learn how to improve care for people living with GVHD.

Who Can Join the Horizons Study?

We are looking for participants who:

Are adult (≥18 yrs) allogeneic transplant survivors

 Have GVHD symptoms

Are willing to participate in a group telehealth workshop in English or Spanish language

What to Expect

Your participation in the Horizons Study will last approximately 18 weeks. Here’s a simple breakdown of what will happen during each phase:

Enrollment Period

(First 4 Weeks)

During this phase, we’ll help you get started:

  • You’ll meet with a member of the study team to go over the details of the study and what participation involves.
  • If you choose to take part, you’ll give your consent and complete your first survey.
  • After that, you’ll be randomly assigned to one of two study groups.

Horizons Workshop Period

(8 Weeks)

Depending on your group assignment, you’ll either join weekly sessions or receive educational materials:

If you’re in the Horizons Group:
  • Attend eight virtual group sessions, once a week.
  • Sessions will be led by both a behavioral health clinician and a transplant clinician.
  • You’ll learn practical tools and support strategies to help manage GVHD.
If you’re in the Educational Group:
  • You’ll receive an educational booklet with trusted, evidence-based information about GVHD care and management.

Post-Workshop Period

(Final 8 Weeks)

As the study wraps up, we’ll check in with you:

  • You’ll be asked to complete 2 short surveys about your experience.
  • If you were in the Horizons Group, you may be invited to join an optional interview to share your feedback about the workshop.

Joining the Study is as Easy as 1-2-3!

1
2
3

Check Your Eligibility

Connect with a study team member to find out if you're eligible.

Contact Horizons Team to Learn More!

Get in Touch

Have questions? Call us at (305-243-0456) to speak with a study team member. We'll walk you through the details and the informed consent process.

Enroll with Support

Once you're ready, a member of our team will guide you through the enrollment—either over the phone or in person, whichever is more convenient for you.

Your Participation Matters

By taking part in this trial, you’re helping researchers and healthcare providers better understand how to improve care for people living with chronic graft-versus-host disease (cGVHD). Your voice and experience can shape future support services. When you take part in a clinical trial, you’re not only contributing to healthcare research—you're helping create a better path forward for others living with cGVHD after transplant.